This inventor holds 3 USPTO granted patents. Top assignee: Chugai Seiyaku Kabushiki Kaisha. Active years: 1998-2004.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1998-2004
Title: Katsuya Matsuda: Innovator in Phosphate-Binding Polymer Technology
Introduction
Katsuya Matsuda is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceutical technology, particularly in the development of phosphate-binding polymers. With a total of 3 patents to his name, Matsuda's work has the potential to impact the treatment of various medical conditions.
Latest Patents
Matsuda's latest patents focus on the preparation of phosphate-binding polymer tablets. One of his notable inventions is a tablet that contains a phosphate-binding polymer with an average particle size of 400 µm or less. This tablet includes particles of 500 µm or less at a ratio of 90% or more and has a moisture content of 1 to 14%. It also incorporates crystalline cellulose and/or low substituted hydroxypropylcellulose. This formulation is designed to bind to phosphate effectively and disintegrate quickly in an acidic to neutral environment. Another patent details a similar tablet and the process for producing it, emphasizing its high active component ratio and its ability to regulate bioavailability changes due to gastrointestinal motions and pH levels.
Career Highlights
Katsuya Matsuda is currently associated with Chugai Seiyaku Kabushiki Kaisha, a leading pharmaceutical company in Japan. His work at Chugai has allowed him to focus on innovative solutions in drug formulation and delivery systems.
Collaborations
Matsuda has collaborated with notable colleagues such as Ryuji Kubota and Koichi Ozawa. Their combined expertise has contributed to the advancement of research in phosphate-binding technologies.
Conclusion
Katsuya Matsuda's innovative work in phosphate-binding polymer technology showcases his commitment to improving pharmaceutical formulations. His patents reflect a deep understanding of the complexities involved in drug delivery systems, making him a valuable contributor to the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
